NOT FOR DISTRIBUTION TO NEWSWIRE SERVICES IN THE UNITED STATES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS
TORONTO, ONTARIO / ACCESSWIRE / August 6, 2019 / MPX International Corporation (“MPX International”, “MPXI” or the “Company”) (CSE:MPXI)(OTC PINK:MPXOF) is pleased to announce that Dr. Amer Cheema and Nicholas Varone are joining the Company as its Vice President, Cultivation and Director of Extraction and Processing, respectively.
Dr. Cheema is an award winning and highly motivated professional with a Ph.D. in Plant Physiology and Biochemistry from the University of Guelph, an International Advanced Diploma in Computer Science and Human Resource Management and over 25 years of multidimensional experience and leadership background in new business development in the cannabis industry and a variety of other plant productions. Dr. Cheema’s experience includes being Head Grower at The Green Organic Dutchman and Director of Cultivation at Goldleaf Pharm/FIRG Inc., a subsidiary of Pyxus International. He brings diverse experience as a cannabis cultivation specialist, hydroponics culture specialist, project management leader, team builder, researcher/teacher and scientist. He has developed a unique “2-step direct flowering cultivation method coupled with other scientific techniques” which provides a methodology to increase the yield of cannabis 100% compared to the industry average high, while maintaining high cannabinoid content.
“We are delighted to welcome Dr. Cheema to our management team,” commented W. Scott Boyes, Chairman, President and CEO of MPX International. “As we continue to develop and manage our operations in Canada, Europe, South Africa, Australia and elsewhere, Dr. Cheema’s experience and expertise in advanced horticultural methodologies will be of critical importance to the speed of implementation as well as the quality and yield of our cannabis cultivation projects.”
Joining MPXI as its Director of Extraction and Processing, the Company welcomes Nicholas Varone. With a degree in Science and several years of extraction experience in multiple U.S. states, Mr. Varone has worked with multiple state-licensed facilities from start-ups to large-scale producers. He brings to MPXI expertise with both hydrocarbon and solventless extraction, lab design, SOP preparation and facility management. Mr. Varone will be working closely with MPXI’s management teams in Canada, Switzerland, Malta, Australia and South Africa as they continue to build-out and operate the Company’s extraction and processing functions in each of these countries.
About MPX International Corporation
MPX International Corporation is focused on developing and operating assets across the global cannabis industry with an emphasis on cultivating, manufacturing and marketing products which include cannabinoids as their primary active ingredient.
Cautionary Statement Regarding Forward-Looking Information
This news release includes certain “forward-looking statements” under applicable Canadian securities legislation that are not historical facts. Forward-looking statements involve risks, uncertainties, and other factors that could cause actual results, performance, prospects, and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements in this news release include, but are not limited to, MPX International’s objectives and intentions. Forward-looking statements are necessarily based on a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic and social uncertainties; litigation, legislative, environmental and other judicial, regulatory, political and competitive developments; delay or failure to receive board, shareholder or regulatory approvals; those additional risks set out in MPX International’s public documents filed on SEDAR at www.sedar.com; and other matters discussed in this news release. Although MPX International believes that the assumptions and factors used in preparing the forward-looking statements are reasonable, undue reliance should not be placed on these statements, which only apply as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Except where required by law, MPX International disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.
For further information, please contact:
SOURCE: MPX International Corporation